9104 Randomized phase III study of...

9104 Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (CTR) for patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): West Japan Thoracic Oncology Group (WJTOG) 0105

Katakami, N., Satouchi, M., Yamamoto, N., Imamura, F., Saka, H., Iwamoto, Y., Saito, H., Nishimura, Y., Chiba, Y., Nakagawa, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71817-8
Date:
September, 2009
File:
PDF, 67 KB
english, 2009
Conversion to is in progress
Conversion to is failed